Compare UTHR & NWSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UTHR | NWSA |
|---|---|---|
| Founded | 1996 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.9B | 14.6B |
| IPO Year | 1999 | N/A |
| Metric | UTHR | NWSA |
|---|---|---|
| Price | $564.81 | $24.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 5 |
| Target Price | ★ $561.57 | $37.94 |
| AVG Volume (30 Days) | 602.2K | ★ 4.6M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.82% |
| EPS Growth | ★ 13.07 | N/A |
| EPS | ★ 27.86 | N/A |
| Revenue | ★ $1,483,300,000.00 | N/A |
| Revenue This Year | $7.05 | $6.06 |
| Revenue Next Year | $13.30 | $3.25 |
| P/E Ratio | $20.25 | ★ $11.53 |
| Revenue Growth | ★ 2.38 | N/A |
| 52 Week Low | $266.98 | $22.20 |
| 52 Week High | $607.89 | $31.61 |
| Indicator | UTHR | NWSA |
|---|---|---|
| Relative Strength Index (RSI) | 59.84 | 51.37 |
| Support Level | $464.92 | $23.51 |
| Resistance Level | N/A | $24.60 |
| Average True Range (ATR) | 17.36 | 0.58 |
| MACD | 3.23 | 0.08 |
| Stochastic Oscillator | 52.29 | 44.50 |
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.
News Corporation is a diversified media conglomerate with large presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings platform in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.